279 related articles for article (PubMed ID: 12712648)
1. [From gene to disease; HFE-mutations in primary haemochromatosis].
Swinkels DW; Jacobs EM
Ned Tijdschr Geneeskd; 2003 Apr; 147(14):652-6. PubMed ID: 12712648
[TBL] [Abstract][Full Text] [Related]
2. Hemochromatosis gene HFE Cys282Tyr mutation analysis in a cohort of Northeast German hospitalized patients supports assumption of a North to South allele frequency gradient throughout Germany.
Meier P; Schuff-Werner P; Steiner M
Clin Lab; 2005; 51(9-10):539-43. PubMed ID: 16285477
[TBL] [Abstract][Full Text] [Related]
3. An unusual case of hemochromatosis due to a new compound heterozygosity in HFE (p.[Gly43Asp;His63Asp]+[Cys282Tyr]): structural implications with respect to binding with transferrin receptor 1.
Dupradeau FY; Pissard S; Coulhon MP; Cadet E; Foulon K; Fourcade C; Goossens M; Case DA; Rochette J
Hum Mutat; 2008 Jan; 29(1):206. PubMed ID: 18157833
[TBL] [Abstract][Full Text] [Related]
4. Testing families with HFE-related hereditary haemochromatosis.
Siezenga MA; Rasp E; Wijermans PW
Neth J Med; 2004 May; 62(5):156-9. PubMed ID: 15366698
[TBL] [Abstract][Full Text] [Related]
5. Review article: the genetic basis of haemochromatosis.
Griffiths WJ
Aliment Pharmacol Ther; 2007 Aug; 26(3):331-42. PubMed ID: 17635368
[TBL] [Abstract][Full Text] [Related]
6. HFE, hepcidin and ferroportin gene mutations are not present in Indian patients with primary haemochromatosis.
Shukla P; Julka S; Bhatia E; Shah S; Nagral A; Aggarwal R
Natl Med J India; 2006; 19(1):20-3. PubMed ID: 16570681
[TBL] [Abstract][Full Text] [Related]
7. [Frequency of HFE gene mutations and genotype-phenotype correlations in patients with hereditary hemochromatosis in Switzerland].
Himmelmann A; Bortoluzzi L; Jansen S; Fehr J
Schweiz Med Wochenschr; 2000 Aug; 130(31-32):1112-9. PubMed ID: 11008304
[TBL] [Abstract][Full Text] [Related]
8. Genetics of hemochromatosis.
Cullen LM; Anderson GJ; Ramm GA; Jazwinska EC; Powell LW
Annu Rev Med; 1999; 50():87-98. PubMed ID: 10073265
[TBL] [Abstract][Full Text] [Related]
9. Predominance of the HLA-H Cys282Tyr mutation in Austrian patients with genetic haemochromatosis.
Datz C; Lalloz MR; Vogel W; Graziadei I; Hackl F; Vautier G; Layton DM; Maier-Dobersberger T; Ferenci P; Penner E; Sandhofer F; Bomford A; Paulweber B
J Hepatol; 1997 Nov; 27(5):773-9. PubMed ID: 9382962
[TBL] [Abstract][Full Text] [Related]
10. [Molecular diagnosis of HFE mutations in routine laboratories. Results of a survey from reference laboratories in France].
Jouanolle AM; Gérolami V; Ged C; Grandchamp B; Le Gac G; Pissard S; Rochette J; Aguilar-Martinez P
Ann Biol Clin (Paris); 2012; 70(3):305-13. PubMed ID: 22565179
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of non-HFE gene-associated haemochromatosis in patients from southern Italy.
De Marco F; Liguori R; Giardina MG; D'Armiento M; Angelucci E; Lucariello A; Morante R; Cimino L; Galeota-Lanza A; Tarantino G; Ascione A; Budillon G; Vecchione R; Martinelli R; Matarazzo M; De Simone V
Clin Chem Lab Med; 2004 Jan; 42(1):17-24. PubMed ID: 15061375
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls.
Sánchez M; Bruguera M; Bosch J; Rodés J; Ballesta F; Oliva R
J Hepatol; 1998 Nov; 29(5):725-8. PubMed ID: 9833909
[TBL] [Abstract][Full Text] [Related]
13. Molecular analysis of HLA-H gene mutations in New Zealand patients with haemochromatosis.
Burt MJ; Upton JD; Morison IM; Chapman BA; Faed JM; George PM
N Z Med J; 1997 Nov; 110(1056):429-32. PubMed ID: 9418837
[TBL] [Abstract][Full Text] [Related]
14. Defective release of Hepcidin not defective synthesis is the primary pathogenic mechanism in HFE-Haemochromatosis.
Arnold J; Sangwaiya A; Bhatkal B; Arnold A
Med Hypotheses; 2008; 70(6):1197-200. PubMed ID: 18054440
[TBL] [Abstract][Full Text] [Related]
15. Reverse cascade screening of newborns for hereditary haemochromatosis: a model for other late onset diseases?
Cadet E; Capron D; Gallet M; Omanga-Léké ML; Boutignon H; Julier C; Robson KJ; Rochette J
J Med Genet; 2005 May; 42(5):390-5. PubMed ID: 15863667
[TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of genetic haemochromatosis].
Milman NT
Ugeskr Laeger; 2013 Apr; 175(16):1109-12. PubMed ID: 23651749
[TBL] [Abstract][Full Text] [Related]
17. Haemochromatosis: automated detection of the two point mutations in the HFE gene: Cys282Tyr and His63Asp.
Klingler KR; Zech D; Wielckens K
Clin Chem Lab Med; 2000 Dec; 38(12):1225-30. PubMed ID: 11205685
[TBL] [Abstract][Full Text] [Related]
18. Abnormal regulation of HFE mRNA expression does not contribute to primary iron overload.
Vercesi E; Cerani P; Rolandi V; Rovati A; Bergamaschi G
Haematologica; 2000 Aug; 85(8):787-91. PubMed ID: 10942923
[TBL] [Abstract][Full Text] [Related]
19. Penetrance of Hemochromatosis in HFE Genotypes Resulting in p.Cys282Tyr and p.[Cys282Tyr];[His63Asp] in the eMERGE Network.
Gallego CJ; Burt A; Sundaresan AS; Ye Z; Shaw C; Crosslin DR; Crane PK; Fullerton SM; Hansen K; Carrell D; Kuivaniemi H; Derr K; de Andrade M; McCarty CA; Kitchner TE; Ragon BK; Stallings SC; Papa G; Bochenek J; Smith ME; Aufox SA; Pacheco JA; Patel V; Friesema EM; Erwin AL; Gottesman O; Gerhard GS; Ritchie M; Motulsky AG; Kullo IJ; Larson EB; Tromp G; Brilliant MH; Bottinger E; Denny JC; Roden DM; Williams MS; Jarvik GP
Am J Hum Genet; 2015 Oct; 97(4):512-20. PubMed ID: 26365338
[TBL] [Abstract][Full Text] [Related]
20. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
